Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01584128 · ClinicalTrials.gov registry record
Oxidized Regenerated Cellulose to Decrease Vaginal Cuff Complications
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 101
- Enrollment target
NCT01584128 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 101 participants.
The verdict
NCT01584128 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The goal of the investigators study is to determine whether the use of oxidized regenerated cellulose reduces the risk of vaginal cuff cellulitis, pelvic abscess, or vaginal cuff dehiscence in patients undergoing laparoscopic hysterectomy. The investigators hypothesize that the use of oxidized regenerated cellulose will reduce the risk of vaginal cuff cellulitis, pelvic abscess, and vaginal cuff dehiscence in patients undergoing laparoscopic hysterectomy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01584128
The ClinicalTrials.gov registry entry for NCT01584128 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01584128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01584128 about?
NCT01584128 is a clinical study titled "Oxidized Regenerated Cellulose to Decrease Vaginal Cuff Complications". The goal of the investigators study is to determine whether the use of oxidized regenerated cellulose reduces the risk of vaginal cuff cellulitis, pelvic abscess, or vaginal cuff dehiscence in patients undergoing laparoscopic hysterectomy. The investigators hypothesize that the use of oxidized regen...
What is the current status of trial NCT01584128?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2012-04. Estimated completion is 2013-03-01.
Who is sponsoring clinical trial NCT01584128?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.